The global molecular diagnostic reagent market is expected to grow at a CAGR of 7.5% during the forecast period, from 2021 to 2030. The growth of this market is driven by the increasing demand for molecular diagnostics in various applications such as hospital, laboratories, research institutes and biopharmaceutical companies. The increasing prevalence of chronic diseases such as cancer and diabetes has led to an increase in the demand for molecular diagnostics which can help detect these diseases at an early stage. The PCR kits segment accounted for the largest share of this market in 2018 due to its high adoption rate among hospitals and laboratories owing to its low cost and easy-to-use features. The sample preparation kit segment is expected to grow at a CAGR of 8% during the forecast period due to its high adoption rate among hospitals owing to its low cost and easy-to-use features.
- The increasing prevalence of chronic diseases such as diabetes and cancer is driving the growth of molecular diagnostic reagents market.
- The increasing number of research and development activities in the field of molecular diagnostics is expected to fuel the growth of molecular diagnostic reagents market in near future.
- The growing demand for point-of-care testing devices is also expected to drive the growth of molecular diagnostic reagents market in near future.
- Increasing government funding for research and development activities related to molecular diagnostics is also expected to fuel the growth of this market in near future.
- Increasing awareness about various types of diseases, their symptoms, diagnosis, treatment options etc, are also expected to drive the growth rate for this market.
Industry Growth Insights published a new data on “Molecular Diagnostic Reagent Market”. The research report is titled “Molecular Diagnostic Reagent Market research by Types (PCR Kits, Sample Preparation Kit, Microarray Kit), By Applications (Hospital, Laboratories, Research Institutes, Biopharmaceutical Companies, Others), By Players/Companies F. Hoffmann-La Roche Ltd., Becton Dickinson, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc., Merck Group, Agilent Technologies, Inc., Qiagen N.V., Illumina, Inc., DiaSorin S.p.A, Hologic Inc.”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Molecular Diagnostic Reagent Market Research Report
By Type
PCR Kits, Sample Preparation Kit, Microarray Kit
By Application
Hospital, Laboratories, Research Institutes, Biopharmaceutical Companies, Others
By Companies
F. Hoffmann-La Roche Ltd., Becton Dickinson, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc., Merck Group, Agilent Technologies, Inc., Qiagen N.V., Illumina, Inc., DiaSorin S.p.A, Hologic Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Molecular Diagnostic Reagent Market Report Segments:
The global Molecular Diagnostic Reagent market is segmented on the basis of:
Types
PCR Kits, Sample Preparation Kit, Microarray Kit
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Laboratories, Research Institutes, Biopharmaceutical Companies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- F. Hoffmann-La Roche Ltd.
- Becton Dickinson
- Bio-Rad Laboratories Inc
- Thermo Fisher Scientific Inc.
- Merck Group
- Agilent Technologies, Inc.
- Qiagen N.V.
- Illumina, Inc.
- DiaSorin S.p.A
- Hologic Inc.
Highlights of The Molecular Diagnostic Reagent Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- PCR Kits
- Sample Preparation Kit
- Microarray Kit
- By Application:
- Hospital
- Laboratories
- Research Institutes
- Biopharmaceutical Companies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Molecular Diagnostic Reagent Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Molecular diagnostic reagent is a type of laboratory test that uses molecules to identify or diagnose a disease. Molecular diagnostics can be used to detect the presence of specific diseases or conditions in body fluids, tissues, and cells.
Some of the major companies in the molecular diagnostic reagent market are F. Hoffmann-La Roche Ltd., Becton Dickinson, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc., Merck Group, Agilent Technologies, Inc., Qiagen N.V., Illumina, Inc., DiaSorin S.p.A, Hologic Inc..
The molecular diagnostic reagent market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Molecular Diagnostic Reagent Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Molecular Diagnostic Reagent Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Molecular Diagnostic Reagent Market - Supply Chain
4.5. Global Molecular Diagnostic Reagent Market Forecast
4.5.1. Molecular Diagnostic Reagent Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Molecular Diagnostic Reagent Market Size (000 Units) and Y-o-Y Growth
4.5.3. Molecular Diagnostic Reagent Market Absolute $ Opportunity
5. Global Molecular Diagnostic Reagent Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Molecular Diagnostic Reagent Market Size and Volume Forecast by Type
5.3.1. PCR Kits
5.3.2. Sample Preparation Kit
5.3.3. Microarray Kit
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Molecular Diagnostic Reagent Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Molecular Diagnostic Reagent Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Laboratories
6.3.3. Research Institutes
6.3.4. Biopharmaceutical Companies
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Molecular Diagnostic Reagent Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Molecular Diagnostic Reagent Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Molecular Diagnostic Reagent Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Molecular Diagnostic Reagent Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Molecular Diagnostic Reagent Demand Share Forecast, 2019-2026
9. North America Molecular Diagnostic Reagent Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Molecular Diagnostic Reagent Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Molecular Diagnostic Reagent Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Laboratories
9.4.3. Research Institutes
9.4.4. Biopharmaceutical Companies
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Molecular Diagnostic Reagent Market Size and Volume Forecast by Type
9.7.1. PCR Kits
9.7.2. Sample Preparation Kit
9.7.3. Microarray Kit
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Molecular Diagnostic Reagent Demand Share Forecast, 2019-2026
10. Latin America Molecular Diagnostic Reagent Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Molecular Diagnostic Reagent Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Molecular Diagnostic Reagent Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Laboratories
10.4.3. Research Institutes
10.4.4. Biopharmaceutical Companies
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Molecular Diagnostic Reagent Market Size and Volume Forecast by Type
10.7.1. PCR Kits
10.7.2. Sample Preparation Kit
10.7.3. Microarray Kit
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Molecular Diagnostic Reagent Demand Share Forecast, 2019-2026
11. Europe Molecular Diagnostic Reagent Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Molecular Diagnostic Reagent Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Molecular Diagnostic Reagent Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Laboratories
11.4.3. Research Institutes
11.4.4. Biopharmaceutical Companies
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Molecular Diagnostic Reagent Market Size and Volume Forecast by Type
11.7.1. PCR Kits
11.7.2. Sample Preparation Kit
11.7.3. Microarray Kit
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Molecular Diagnostic Reagent Demand Share, 2019-2026
12. Asia Pacific Molecular Diagnostic Reagent Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Molecular Diagnostic Reagent Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Molecular Diagnostic Reagent Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Laboratories
12.4.3. Research Institutes
12.4.4. Biopharmaceutical Companies
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Molecular Diagnostic Reagent Market Size and Volume Forecast by Type
12.7.1. PCR Kits
12.7.2. Sample Preparation Kit
12.7.3. Microarray Kit
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Molecular Diagnostic Reagent Demand Share, 2019-2026
13. Middle East & Africa Molecular Diagnostic Reagent Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Molecular Diagnostic Reagent Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Molecular Diagnostic Reagent Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Laboratories
13.4.3. Research Institutes
13.4.4. Biopharmaceutical Companies
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Molecular Diagnostic Reagent Market Size and Volume Forecast by Type
13.7.1. PCR Kits
13.7.2. Sample Preparation Kit
13.7.3. Microarray Kit
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Molecular Diagnostic Reagent Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Molecular Diagnostic Reagent Market: Market Share Analysis
14.2. Molecular Diagnostic Reagent Distributors and Customers
14.3. Molecular Diagnostic Reagent Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. F. Hoffmann-La Roche Ltd.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Becton Dickinson
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bio-Rad Laboratories Inc
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Thermo Fisher Scientific Inc.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Merck Group
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Agilent Technologies, Inc.
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Qiagen N.V.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Illumina, Inc.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. DiaSorin S.p.A
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Hologic Inc.
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook